BioNTech SE (NASDAQ:BNTX) reported a third-quarter per-share loss of 14 cents (12 cents in euros) on Monday, a turnaround from earnings of 81 cents reported a year ago, missing the consensus earnings of 75 cents per share.BNTX shares are consolidating after recent moves. See what the experts say hereThe COVID-19 vaccine maker reported sales of $1.78 billion (1.52 billion euros), compared to 1.24 billion euros a year ago, beating the consensus of$1.19 billion.The increase was primarily driven by revenues re ...